hydroxychloroquine

Response to: ‘Correspondence on ‘Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist’ by Graef et al’ by Lo et al
Ali Duarte-García, Elizabeth R Graef, Jean W Liew, Maximilian F Konig, Alfred Hyoungju Kim, Jeffrey A Sparks

Annals of the Rheumatic Diseases Sep 2022, 81 (9) e164; DOI: 10.1136/annrheumdis-2020-218680
Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’
Rui Gao, Lang Qin

Annals of the Rheumatic Diseases May 2023, 82 (5) e106; DOI: 10.1136/annrheumdis-2021-220092
Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19’ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France
Emilie Sbidian, Laetitia Penso, Philippe Herlemont, Jérémie Botton, Bérangère Baricault, Laura Semenzato, Jérome Drouin, Alain Weill, Rosemay Dray-Spira, Mahmoud Zureik

Annals of the Rheumatic Diseases May 2023, 82 (5) e117; DOI: 10.1136/annrheumdis-2020-218647
Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial
Noemie Jourde-Chiche, Nathalie Costedoat-Chalumeau, Karine Baumstarck, Anderson Loundou, Laurence Bouillet, Stéphane Burtey, Valérie Caudwell, Laurent Chiche, Lionel Couzi, Laurent Daniel, Christophe Deligny, Bertrand Dussol, Stanislas Faguer, Pierre Gobert, Guillaume Gondran, Antoine Huart, Aurélie Hummel, Emilie Kalbacher, Adexandre Karras, Marc Lambert, Véronique Le Guern, Ludivine Lebourg, Sandrine Loubière, Hélène Maillard-Lefebvre, François Maurier, Micheline Pha, Viviane Queyrel, Philippe Remy, Françoise Sarrot-Reynauld, David Verhelst, Eric Hachulla, Zahir Amoura, Eric Daugas

Annals of the Rheumatic Diseases Oct 2022, 81 (10) 1420-1427; DOI: 10.1136/annrheumdis-2022-222435
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus
Chia-Ying Wu, Magdalene Tan, Jing-Yang Huang, Jeng-Yuan Chiou, James Cheng-Chung Wei

Annals of the Rheumatic Diseases May 2022, 81 (5) e75; DOI: 10.1136/annrheumdis-2020-217728
Response to: ‘Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus’ by Wu et al
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

Annals of the Rheumatic Diseases May 2022, 81 (5) e76; DOI: 10.1136/annrheumdis-2020-217804
Response to: ‘COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases’ by Lopez-Medina et al
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna

Annals of the Rheumatic Diseases Apr 2021, 80 (4) e51; DOI: 10.1136/annrheumdis-2020-218070
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’
Mandana Nikpour, Benjamin Teh, Ian P Wicks, Marc Pellegrini

Annals of the Rheumatic Diseases Mar 2021, 80 (3) e33; DOI: 10.1136/annrheumdis-2020-217827
Hydroxychloroquine and lupus flare: a good drug, but we need to do better
Mary K Crow, Kyriakos A Kirou

Annals of the Rheumatic Diseases Mar 2022, 81 (3) 303-305; DOI: 10.1136/annrheumdis-2021-221590
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Celline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle Petri, Ellen M Ginzler, D J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary Anne Dooley, Christine Peschken, David Isenberg, Anisur Rahman, Susan Manzi, Søren Jacobsen, Sam Lim, Ronald F van Vollenhoven, Ola Nived, Andreas Jönsen, Diane L Kamen, Cynthia Aranow, Jorge Sanchez-Guerrero, Dafna D Gladman, Paul R Fortin, Graciela S Alarcón, Joan T Merrill, Kenneth Kalunian, Manuel Ramos-Casals, Kristján Steinsson, Asad Zoma, Anca Askanase, Munther A Khamashta, Ian N Bruce, Murat Inanc, Michal Abrahamowicz, Sasha Bernatsky

Annals of the Rheumatic Diseases Mar 2022, 81 (3) 370-378; DOI: 10.1136/annrheumdis-2021-221295

Main menu

hydroxychloroquine

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

hydroxychloroquine

Pages